The Pathophysiologic Basis for Hemodialysis‐Related Hypotension

Seminars in Dialysis

Volumn 1, Issue 3, 1988, Pages 136-142

  Sherman, Richard A ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002557028     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.1988.tb00747.x     Document Type: Review

References (106)

1. Hypotension during hemodialysis
2. Epidemiology of dialysis induced hypotension
3. Dialysis symptoms and stabilization in long‐term dialysis
4. Hypotension and closure of hemodialysis access shunts
5. Transcapillary colloid osmotic gradient and body fluid volumes in renal failure
6. Transcapillary fluid absorption and other vascular reactions in the human forearm during reduction of the circulating blood volume
7. Plasma volume recovery after ultrafiltration in patients with chronic renal failure
8. Urea dynamics during and immediately after dialysis
9. Symptomatic hypotension during hemodialysis
10. Effect of hemodialysis on blood volume distribution and cardiac output
11. Autonomic function in patients with chronic renal failure on intermittent haemodialysis
12. Autonomic function in uremic patients treated by hemodialysis or CAPD and in transplant patients
13. Mechanisms of autonomic nervous system dysfunction in uremia
14. Carotid baroreflexes during hemodialysis
15. Adrenergic regulation of blood pressure in chronic renal failure
16. Autonomic insufficiency in uremia as a cause of hemodialysis‐induced hypotension
17. Hemodialysis hypotension is not the result of uremic peripheral autonomic neuropathy
18. Autonomic neuropathy and symptomatic hypotension in hemodialysis patients
19. Hemodynamic evaluation of hypotension during chronic hemodialysis
20. Hemodynamic changes during sequential ultrafiltration and dialysis
21. Blood pressure response to hemodialysis
22. Hemodynamic changes induced by regular hemodialysis and sequential ultrafiltration hemodialysis: A comparative study
23. Hemodynamic study of hypotension during hemodialysis
24. Depressant action of acetate upon the human cardiovascular system
25. Cardiac and vascular effects of infused sodium acetate in dogs
26. + on dog limb and coronary vascular resistances
27. Comparison of hemodynamics induced by conventional acetate hemodialysis, bicarbonate hemodialysis and ultrafiltration
28. Less dialysis‐induced morbidity and vascular instability with bicarbonate in dialysate
29. Effects of acetate and bicarbonate dialysate in stable chronic dialysis patients
30. Bicarbonate hemodialysis: Influence on plasma refilling and hemodynamic stability
31. Influence of left ventricular function on changes in plasma volume during acetate and bicarbonate dialysis
32. The influence of dialysis fluid composition on dialysis tolerance
33. Acetate intolerance during hemodialysis
34. Acetate appearance curve in notmotensive and hypotension‐prone hemodialysis patients
35. Serum levels of acetate and TCA cycle intermediates during hemodialysis in relation to symptoms
36. Incidence and significance of rising blood acetate levels during hemodialysis
37. Acetate and bicarbonate fluctuations and acetate intolerance during dialysis
38. Effects of acetate and bicarbonate hemodialysis on cardiac function in chronic dialysis patients
39. Acetate‐induced myocardial depression during hemodialysis for acute renal failure
40. Acetate dialysate versus bicarbonate dialysate: A continuing controversy
41. Contrasting alterations in pulmonary gas exchange during acetate and bicarbonate hemodialysis
42. Respiratory gas exchange by high‐efficiency hemodialyzers
43. High sodium bicarbonate and acetate hemodialysis: Double‐blind crossover comparison of hemodynamic and ventilatory effects
44. Prevention of dialysis‐induced hypoxemia by bicarbonate dialysis
45. Gas exchange during dialysis: Contrasting mechanisms contribution to comparable alteration with acetate and bicarbonate buffers
46. Acetate, bicarbonate and hypotension during hemodialysis
47. Effects of oxygen administration on the manifestation of acetate intolerance in dialysis patients
48. Hypoxemia and hemodialysis‐induced symptomatic hypotension
49. The influence of dialysis fluid composition on the blood pressure response during dialysis
50. Acetate and bicarbonate hemodialysis in patients with and without autonomic dysfunction
51. Benefits obtained by the use of high sodium dialysate during maintenance haemodialysis
52. Crossover study of the effects of different dialysate sodium concentrations in large surface area, short‐term dialysis
53. A double blind crossover comparison of high and low sodium dialysis
54. Hemodialysis with adequate sodium concentration in dialysate
55. Effects of high sodium dialysate during maintenance hemodialysis
56. Effects of varying dialysate sodium using large surface area dialyzers
57. The chronic efficacy and safety of high sodium dialysate: Double‐blind, crossover study
58. A critical examination of dialysis‐induced hypotension
59. Model prediction of plasma volume change induced by hemodialysis
60. Preservation of plasma volume during hemodialysis depends on dialysate osmolality
61. Rote of osmolality in blood pressure stability after dialysis and ultrafiltration
62. Decreased postdialysis fatigue with increased dialysate sodium concentration
63. Hemodynamics of uremic anemia
64. Blood pressure regulation in chronic hypotensive and hypertensive patients with chronic renal failure
65. The effect of red cell transfusion on hemodialysis‐related hypotension
66. Serum calcium in blood pressure regulation during hemodialysis
67. Increased ionized calcium and left ventricular contractility during hemodialysis
68. Effect of hemodialysis on left ventricular function
69. Blood pressure response to changes in serum ionized calcium during hemodialysis
70. The effect of dialysate calcium levels on blood pressure during hemodialysis
71. Extreme hypermagnesemia as a cause of refractory hypotension
72. Hypermagnesemia as a cause of refractory hypotension, respiratory depression, and coma
73. The cause of inadequate haemodynamic reactions during ultradiffusion
74. Competitive effects of hypokalemia and volume depletion on plasma renin activity, aldosterone and catecholamine concentrations in hemodialysis patients
75. Local effects of hypokalemia on coronary resistance and myocardial contractile force
76. Hemodynamics in hemofiltration
77. Hemofiltration and vascular stability
78. A sheep model to examine the cardiopulmonary manifestations of blooddialyzer interactions
79. Complement activation and hypersensitivity reactions to dialysis membranes
80. Anaphylatoxin formation during hemodialysis: Comparison of new and re‐used dialyzers
81. Effect of first and subsequent use of hemodialyzers on patient well‐being
82. Long‐term results of dialysis therapy with a highly permeable membrane
83. Response of the vascular system to different modifications of haemoflltration and haemodialysis
84. Sympathetic and hemodynamic response to volume removal during different forms of renal replacement therapy
85. Changes in plasma catecholamine levels during hemodialysis
86. Plasma catecholamine response to postural stimulation in normotensive and dialysis hypotension‐prone uremic patients
87. Blood temperature and vascular stability during hemodialysis and hemofiltration
88. Amelioration of hemodialysis‐associated hypotension by the use of cool dialysate
89. Cold as cardiovascular stabilizing factor in hemodynamic evaluation
90. Temperature and vascular stability in hemodialysis
91. Cardiovascular stability in low temperature dialysis
92. Effect of variations in dialysate temperature on blood pressure during hemodialysis
93. Effect of cooled dialysate on serum catecholamines and blood pressure stability
94. Hemodialysis hypotension: The interkukin hypothesis
95. The effect of dialysate temperature on haemodialysis leucopenia
96. 2 promotes hypotension on low‐sodium hemodialysis
97. The effect of prostaglandin inhibition on the clinical course of chronic hemodialysis
98. Obstruction of the inferior vena Cava complicating hemodialysis in polycystic kidney disease
99. Hypertrophic cardiomyopathy: An acquired disorder of end‐stage renal disease
100. Effects of antihyperensive drugs on dialysis‐resistant hypertension, plasma renin and dopamine betahydroxylase activities, metabolic risk factors and calcium phosphate homeostasis; comparison of metoprolol, alphamethyldopa and clonindine in a cross‐over trial
101. Postprandial alterations in hemodynamics and blood pressure in normal subjects
102. The effect of oral protein and glucose feeding on splanchnic blood flow and oxygen utilization in normal and cirrhotic subjects
103. Effect of food on hepatic blood flow: Implications in the “food effect” phenomenon
104. Glucose and baroreceptor function
105. Glucose‐enriched dialysate and tolerance to maintenance hemodialysis